A new streaming documentary has pushed keto’s loudest argument beyond the scale and into the cardiology lab. The Cholesterol Code follows one man’s health journey into a broader challenge to how elevated cholesterol is interpreted, and its official site says the film comes with a research section and educational materials.
That timing matters because the latest keto conversation is no longer just about fat loss. A 2025 review and meta-analysis on polycystic ovary syndrome found ketogenic diets and very-low-energy ketogenic therapy may be a promising short-term intervention for women with PCOS and a body mass index above 25, while also warning that study heterogeneity and differences in quality make the evidence uneven. Another 2025 review summarized 14 studies and 643 participants, reporting improvements in weight, insulin sensitivity, and reproductive hormone profiles, including lower luteinizing hormone and testosterone. For readers who track the PCOS side of keto, that shifts the focus from headline weight changes to the hormone and cycle markers that matter day to day.
The same pattern shows up in diabetes. A Frontiers in Nutrition case study followed a 49-year-old man in India with new-onset type 2 diabetes and a baseline HbA1c of 7.2%. His carbohydrate intake moved in phases, starting at about 100 grams a day, dropping below 30 grams during nutritional ketosis, and later settling around 100 grams again. Over 10 years, his HbA1c stayed between 4.7% and 5.3% without medication, his continuous glucose monitor time-in-range stayed above 90%, lipoprotein(a) fell from 43.4 to 25.3 mg/dL, hs-CRP remained below 1 mg/L, and three coronary artery calcium scans stayed at 0. For keto followers, that is the real debate now: not whether keto can change weight quickly, but which biomarkers move, which ones stay stable, and how flexible the carb ceiling can be once metabolic control is established.
The conversation is widening again in mental health. Stanford Medicine said in April 2025 that growing scientific evidence suggests ketogenic therapy can help some patients with serious mental illness manage metabolic health and improve psychiatric symptoms. It pointed to a pilot study of 21 adults with bipolar disorder or schizophrenia and metabolic disorders, where both psychiatric and metabolic improvements were seen after four months on a ketogenic diet. That puts keto in a different lane from the usual beach-body framing. It starts to look like a therapeutic tool, one that crosses clinic specialties.
Federal nutrition policy is moving in the same direction. The 2025-2030 Dietary Guidelines for Americans were released on January 7, 2026, and USDA’s 2026 guidance says some people with chronic diseases may experience improved outcomes on a lower carbohydrate diet. Put together, the documentary, the PCOS data, the diabetes case study, and the new guidelines suggest keto is maturing into something broader than a weight-loss template. The center of gravity is shifting toward biomarkers, individual response, and therapeutic use, and that is changing what serious keto looks like in real life.
This article was produced by Prism’s automated news system from verified source data, official records, and press releases, then run through automated quality and moderation checks before publishing. The system is built and supervised by the people who set the standards it runs under. Read our full AI policy.
Know something we missed? Have a correction or additional information?
Submit a Tip
